Breadcrumb

What’s new at The Institute?

England’s successful diabetes prevention program as blueprint for Canada

Canada can learn from England's diabetes prevention program to build its own initiatives to combat rising rates...

New blood test aims to detect aggressive prostate cancer earlier

By identifying cancer-specific methylation signals in blood, researchers hope to enable safer, earlier detection of high-risk prostate cancer

The Institute’s Clinical Observership Program: Bridging lab research and patient care

Four postdoctoral trainees take part in a new initiative that deepens their understanding of the diseases...

Better breathing, better treatment for COPD

New research from researchers at The Institute finds that nearly a third of patients with COPD are at risk of using inhalers ill-suited to their breathing...

Team from The Institute selected for XPRIZE Healthspan award

Gustavo Duque and the Canadian Translational Geroscience Network awarded $250,000 and selected to advance in the $101 million competition

Researchers uncover novel immune mechanism that protects the intestine

By studying intestinal worms, scientists from The Institute make a breakthrough in gut immunity—opening the door...

First patients in Canada enrolled in global radioligand therapy trial for metastatic cancer

One year after becoming the first centre in Canada to open a clinical trial of a radioligand therapy for metastatic...

Future of HIV Diagnostics: Experts chart a path forward

A new review in The Lancet HIV, co-authored by Dr. Nitika Pant Pai, highlights innovative tools—from AI to quantum diagnostics—poised to...

Awards for Equity, Diversity and Inclusion in health care research

The Institute celebrates academic excellence of medical and health science students from equity seeking groups

Vaping cannabis could harm your lungs

Two recent studies from The Institute suggest that cannabis vapour may have adverse effects on lung cells.

Learn more about the RI-MUHC